title: Phase I trials in paediatric oncology--the European perspective. The New Agents Group of the United Kingdom Childrens Cancer Study Group.
abstract: The current recommendations for Phase I trials should allow more confident interpretation of the toxicity and efficacy of new agents by providing a framework for multicentre and international co-operation. An overview of the aims and designs of Phase I trials is presented, along with a summary of current and recently published United Kingdom Childrens Cancer Study Group Phase I trials, and a discussion of some of the difficulties faced in the methodology and evaluation of Phase I studies in children.
authors.affiliation: Dept. of Child Health, Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
authors.forename: E J
authors.initials: EJ
authors.lastname: Estlin
authors.forename: S
authors.initials: S
authors.lastname: Ablett
authors.forename: D R
authors.initials: DR
authors.lastname: Newell
authors.forename: I J
authors.initials: IJ
authors.lastname: Lewis
authors.forename: L
authors.initials: L
authors.lastname: Lashford
authors.forename: A D
authors.initials: AD
authors.lastname: Pearson
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D017321:Clinical Trials, Phase I as Topic; D005060:Europe; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents